Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

INO Inovio Pharmaceuticals Inc New

10,70

-0,48 (-4,29%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Inovio Pharmaceuticals Charts.

Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Inovio Pharmaceuticals Charts.

News Inovio Pharmaceuticals Inc New

INOVIO Reports Inducement Grants Under Inducement Plan
Mittwoch 1 Mai 2024 (1 Woche vor) • PR Newswire (US)

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
Montag 29 April 2024 (2 Wochen vor) • PR Newswire (US)

INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Dienstag 16 April 2024 (4 Wochen vor) • PR Newswire (US)

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
Dienstag 26 März 2024 (1 Monat vor) • PR Newswire (US)

INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Mittwoch 6 März 2024 (2 Monate vor) • PR Newswire (US)

Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Mittwoch 6 März 2024 (2 Monate vor) • PR Newswire (US)

U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb
Mittwoch 6 März 2024 (2 Monate vor) • IH Market News

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
Mittwoch 21 Februar 2024 (3 Monate vor) • PR Newswire (US)

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Mittwoch 7 Februar 2024 (3 Monate vor) • PR Newswire (US)

INOVIO Reports Inducement Grant Under Inducement Plan
Freitag 2 Februar 2024 (3 Monate vor) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Donnerstag 1 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Freitag 26 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Inovio Pharmaceuticals Inc New News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen